ProPhase Labs, Inc.
NASDAQ:PRPH
1.43 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | ProPhase Labs, Inc. |
Symbool | PRPH |
Munteenheid | USD |
Prijs | 1.43 |
Beurswaarde | 27,282,255 |
Dividendpercentage | 0% |
52-weken bereik | 1.36 - 7.48 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Ted William Karkus |
Website | https://www.prophaselabs.com |
An error occurred while fetching data.
Over ProPhase Labs, Inc.
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)